Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Ellis

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Current Oncology (Toronto, Ont.)|November 24, 2023
Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of DiseaseArani Sathiyapalan, Ziad Baloush, Peter M Ellis
Current Oncology (Toronto, Ont.)|July 21, 2021
Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS RelapsePeter M Ellis, Anand Swaminath, Gregory R Pond
Clinical Lung Cancer|July 5, 2016
Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung CancerDavid E Dawe, Gregory R Pond, Peter M Ellis
Clinical Lung Cancer|June 24, 2014
Brain metastases in non-small-cell lung cancerDavid E Dawe, Jeffrey N Greenspoon, Peter M Ellis
Clinical Lung Cancer|April 19, 2017
Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic ReviewPeter M Ellis, Emily T Vella, Yee C Ung
Current Oncology (Toronto, Ont.)|December 22, 2022
Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-AnalysisArani Sathiyapalan, Michela Febbraro, Gregory R Pond, et al.
Clinical Lung Cancer|April 2, 2014
Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatmentHumaid O Al-Shamsi, Abdulaziz Al Farsi, Peter M Ellis
Current Oncology (Toronto, Ont.)|November 26, 2025
A Narrative Review of the Strengths and Limitations of Real-World Evidence in Comparison to Randomized Clinical Trials: What Are the Opportunities in Thoracic Oncology for Real-World Evidence to Shine?Peter M Ellis, Larissa Long, Courtney H Coschi, et al.
Journal of Geriatric Oncology|October 16, 2018
The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, CanadaJordan Doherty, David E Dawe, Gregory R Pond, et al.
Palliative Medicine|August 17, 2011
Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysisPaul Cameron, Peter M Ellis, Gregory R Pond, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Current Oncology (Toronto, Ont.)|November 24, 2023
Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of DiseaseArani Sathiyapalan, Ziad Baloush, Peter M Ellis
Current Oncology (Toronto, Ont.)|July 21, 2021
Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS RelapsePeter M Ellis, Anand Swaminath, Gregory R Pond
Clinical Lung Cancer|July 5, 2016
Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung CancerDavid E Dawe, Gregory R Pond, Peter M Ellis
Clinical Lung Cancer|June 24, 2014
Brain metastases in non-small-cell lung cancerDavid E Dawe, Jeffrey N Greenspoon, Peter M Ellis
Clinical Lung Cancer|April 19, 2017
Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic ReviewPeter M Ellis, Emily T Vella, Yee C Ung
Current Oncology (Toronto, Ont.)|December 22, 2022
Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-AnalysisArani Sathiyapalan, Michela Febbraro, Gregory R Pond, et al.
Clinical Lung Cancer|April 2, 2014
Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatmentHumaid O Al-Shamsi, Abdulaziz Al Farsi, Peter M Ellis
Current Oncology (Toronto, Ont.)|November 26, 2025
A Narrative Review of the Strengths and Limitations of Real-World Evidence in Comparison to Randomized Clinical Trials: What Are the Opportunities in Thoracic Oncology for Real-World Evidence to Shine?Peter M Ellis, Larissa Long, Courtney H Coschi, et al.
Journal of Geriatric Oncology|October 16, 2018
The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, CanadaJordan Doherty, David E Dawe, Gregory R Pond, et al.
Palliative Medicine|August 17, 2011
Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysisPaul Cameron, Peter M Ellis, Gregory R Pond, et al.
Pageof 10